# PKC isoform-specific targeting of the phosphorylation site Serine191 in the GIRK4 subunit induces receptor-dependent modulation of GIRK channel activity

**Authors:** Leonie Inderwiedenstraße, Marie-Cécile Kienitz

PMC · DOI: 10.1007/s00424-026-03157-0 · 2026-03-19

## TL;DR

This study shows that different PKC isoforms target specific phosphorylation sites in GIRK4 channels, leading to receptor-specific regulation of channel activity.

## Contribution

The study identifies that PKCε, activated by Angiotensin II, targets the S191 phosphorylation site in GIRK4, while PKCα activated by α1B-ARs does not.

## Key findings

- Phosphorylation-deficient GIRK4 (S191A) channels show reduced inhibition by Ang II via PKCε.
- Mutation of S191 does not affect α1B-AR-induced GIRK channel inhibition, indicating PKCα does not target this site.
- Different GqPCR-activated PKC isoforms target distinct phosphorylation sites in GIRK4.

## Abstract

G Protein activated inwardly rectifying K+ (GIRK) channels are inhibited during stimulation of Gq Protein-coupled receptors (GqPCRs) by depletion of phosphatidyl-4,5-bisphosphate (PIP2) and/or channel phosphorylation by proteinkinase C (PKC). Receptor-specific effects of Gq signaling pathways on GIRK channel activity comprise the activation of different PKC isoforms that target distinct phosphorylation sites within the GIRK4 subunit. The serine residue S191 in the GIRK4 subunit is an important phosphorylation site for PKC which contributes to GIRK channel inhibition. Until now, the specific PKC isoform that phosphorylates this residue is unknown. Furthermore, the functional impact of S191 for Gq-receptor-specific GIRK channel modulation has not been investigated. To evaluate the contribution of this PKC phosphorylation site to receptor-specific GIRK channel modulation, we monitored the activity of phosphorylation-deficient GIRK4 (S191A) channel mutants during stimulation of adrenergic α1B-receptors (α1B-ARs) or Angiotensin AT1-receptors. GqPCR-dependent modulation of GIRK currents was analyzed in voltage-clamp experiments in rat atrial myocytes and in CHO cells expressing phosphorylation-deficient GIRK channels of various subunit compositions. As a novel finding, we demonstrate that the inhibition of phosphorylation-deficient GIRK4 (S191A) channels is impaired during stimulation of AT1-Rs, indicating that this phosphorylation site is targeted at least by the Angiotensin II-activated PKCε isoform. In contrast, ablation of the S191 phosphorylation site does not attenuate phenylephrine-induced GIRK reduction, suggesting that S191 is not a primary target for the α1B-AR activated PKCα. Our data indicate that the different GqPCR-activated PKC isoforms target distinct phosphorylation sites within the GIRK4 subunit, resulting in receptor-specific regulation of the phosphorylation-deficient GIRK4 (S191A) channel mutant.

The online version contains supplementary material available at 10.1007/s00424-026-03157-0.

Phosphorylation-deficient GIRK4 (S191A) channels display reduced PMA-mediated inhibitionMutation of S191 alleviates the inhibitory effect of Ang II on GIRK channel activityResidue S191 is targeted by the AT1-R-activated PKCεGIRK4 (S191A) inhibition was not abrogated during stimulation of α1B-ARsα1B-AR-activated PKCα does not target S191

Phosphorylation-deficient GIRK4 (S191A) channels display reduced PMA-mediated inhibition

Mutation of S191 alleviates the inhibitory effect of Ang II on GIRK channel activity

Residue S191 is targeted by the AT1-R-activated PKCε

GIRK4 (S191A) inhibition was not abrogated during stimulation of α1B-ARs

α1B-AR-activated PKCα does not target S191

The online version contains supplementary material available at 10.1007/s00424-026-03157-0.

## Linked entities

- **Proteins:** KCNJ5 (potassium inwardly rectifying channel subfamily J member 5), PRRT2 (proline rich transmembrane protein 2), PRKCE (protein kinase C epsilon), PRKCA (protein kinase C alpha), AGTR1 (angiotensin II receptor type 1)
- **Chemicals:** Ang II (PubChem CID 172198), PMA (PubChem CID 171116383)
- **Species:** Rattus norvegicus (taxon 10116), Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** KCNJ6 (potassium inwardly rectifying channel subfamily J member 6) [NCBI Gene 3763] {aka BIR1, GIRK-2, GIRK2, KATP-2, KATP2, KCNJ7}, Alb (albumin) [NCBI Gene 24186] {aka Alb1, Albza}, ADRA1B [NCBI Gene 103160164], PRRT2 (proline rich transmembrane protein 2) [NCBI Gene 112476] {aka BFIC2, BFIS2, DSPB3, DYT10, EKD1, FICCA}, Tf (transferrin) [NCBI Gene 24825] {aka Tfn, Trf}, Prkcg (protein kinase C, gamma) [NCBI Gene 24681] {aka PKC, PKCI, Prkc, Prkcc, RATPKCI}, Kcnj5 (potassium inwardly-rectifying channel, subfamily J, member 5) [NCBI Gene 29713], KCNJ5 (potassium inwardly rectifying channel subfamily J member 5) [NCBI Gene 3762] {aka CIR, GIRK4, KATP1, KIR3.4, LQT13}, kcnj5.L (potassium inwardly rectifying channel subfamily J member 5 L homeolog) [NCBI Gene 378557] {aka cir, girk4, katp1, kcnj5, kcnj5-A, kir3.4}, kcnj3.S (potassium inwardly rectifying channel subfamily J member 3 S homeolog) [NCBI Gene 108702960] {aka girk, girk1, kga, kir3.1}
- **Diseases:** dislocation (MESH:D004204), infection (MESH:D007239), atrial tachycardia-induced remodelling (MESH:D064752)
- **Chemicals:** GTP-gamma-S (MESH:D016244), N-acetyl-cysteine (MESH:D000111), phenylephrine (MESH:D010656), Ba (MESH:D001464), (ACh) (MESH:D000109), DAG (MESH:D004075), GTP (MESH:D006160), 2,3-Butanedione monoxime (MESH:C004717), pyruvic acid (MESH:D019289), Kanamycin (MESH:D007612), KOH (MESH:C029943), taurine (MESH:D013654), Gentamycin (MESH:D005839), hygromycin B. (MESH:D006921), selenium (MESH:D012643), NaCl (MESH:D012965), EGTA (MESH:D004533), Phe (MESH:D010649), PIP2 (MESH:D019269), Guanosine 5'-triphosphate sodium salt hydrate (-), fatty acid (MESH:D005227), KCl (MESH:D011189), Lipofectamine (MESH:C086724), MgCl2 (MESH:D015636), K+ (MESH:D011188), CaCl2 (MESH:D002122), NaOH (MESH:D012972), lipid (MESH:D008055), PMA (MESH:D013755), HEPES (MESH:D006531)
- **Species:** Canis lupus familiaris (dog, subspecies) [taxon 9615], Rattus norvegicus (brown rat, species) [taxon 10116], Bos taurus (bovine, species) [taxon 9913], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Xenopus laevis (African clawed frog, species) [taxon 8355]
- **Mutations:** S143F, S185A, S143T, S209A, Phe to 10, serine 227, cysteine to threonine, serine221, serine with alanine, S91A, I229L, S185, S418, S221A, T70A, serine/threonine, S191A, S196, I229, S143, T37A, S320A, S196Q, S418A, S350A, T67A, S233A, 143T, S241A, G418, S227A, S196E, C216T
- **Cell lines:** CHO — Cricetulus griseus (Chinese hamster), Spontaneously immortalized cell line (CVCL_0213), HEK — Homo sapiens (Human), Transformed cell line (CVCL_0045), COS-7 — Chlorocebus aethiops (Green monkey), Transformed cell line (CVCL_0224), 3C — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_1098)

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12999607/full.md

---
Source: https://tomesphere.com/paper/PMC12999607